The USD/CAD Pair: A Look at Recent Movement Intraday Dip to Sub-1.3800 Levels The USD/CAD pair recently experienced a dip to sub-1.3800 levels, reaching a one-week low. However, this downturn was short-lived as dip-buying quickly ensued, propelling the pair to touch a fresh daily top during the early part of the European session on Tuesday….
Do you know how much does Facebook Pay For Views in 2024? The Changing Landscape of Online Monetization The trend of making money is changing. Earlier, people around made money online through YouTube videos. Nowadays, most of the social media enabled monetization facilities, helping influencers to make money online through videos and shots. Today, we…
The Current State of Healthcare Stocks Healthcare stocks fail to keep up with the market Despite the overall success of the S&P 500, healthcare stocks have struggled to make significant gains in the past year. While the S&P 500 has seen a 21% increase in value, healthcare stocks are barely holding on to positive territory….
Royal Caribbean’s Surprising Quarterly Earnings Report In an unexpected turn of events, Royal Caribbean International (RCL) recently reported earnings of $1.63 per share for the fourth quarter of 2021, surpassing the Zacks Consensus Estimate of $1.50 per share. This impressive figure represents a significant leap from the earnings of $1.25 per share reported in the…
Fundamental Overview Crude Oil Market Crude oil has been on the backfoot ever since the last US NFP report as the market might have started to question the reasons to push into even higher highs. Things got even murkier as Trump’s odds of winning soared after the failed assassination attempt. He is a great supporter…
FTAI Aviation Ltd. (FTAI) Securities Class Action Lawsuit: What Does It Mean for Investors and the World? On February 25, 2025, a securities class action lawsuit was filed against FTAI Aviation Ltd. (FTAI) in the United States District Court for the Southern District of New York. The lawsuit alleges that FTAI and certain of its…
Rhenium (186 Re) Obisbemeda: A Promising Treatment for Glioblastoma In a recent development, Plus Therapeutics, Inc. announced the publication of results from a Phase 1 clinical trial of Rhenium (186 Re) Obisbemeda in the prestigious medical journal, Nature Communications. This trial focused on the treatment of recurrent glioblastoma (GBM), a type of brain cancer known…
The Reign of Goldman Sachs: A Dominant Force in Financial Services Goldman Sachs, a globally recognized name in the financial services industry, has been making waves for decades. With a market capitalization of over $200 billion (as of 2021), this New York-based investment bank has solidified its position as a leading player in various sectors,…
